BSE filing, NSE: PBMPOLY. Summary written from the filing by ALFA Finder's alert engine.
PBM Polytex Ltd: key numbers
- Share price
- ₹57.19
- Market cap
- ₹39.34 Cr
- Revenue (annual)
- ₹166.5 Cr
- Net profit (annual)
- ₹-1.57 Cr
- P/E (TTM)
- 21.3×Sector 49.5×
- Promoter holding
- 68.24%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PBM Polytex Ltd
All →PBM Polytex Annual General Meeting
PBM Polytex Ltd concluded its 107th Annual General Meeting on September 28, 2026. Key resolutions included adoption of financial results and re-appointment of Managing Directors.
PBM Polytex Other Announcement
PBM Polytex Ltd notified shareholders regarding the dispatch of physical letters containing the Annual Report 2025-26 weblink and KYC update reminders. The 107th AGM is scheduled for September 28, 2026.
PBM Polytex Annual Report
PBM Polytex Limited has submitted its 107th Annual Report for the Financial Year 2025-26. The document includes the notice for the upcoming Annual General Meeting.
PBM Polytex Annual General Meeting
PBM Polytex Ltd has issued a notice for its 107th Annual General Meeting scheduled for September 28, 2026. Key agenda items include director re-appointments and audit ratifications.
PBM Polytex Management Change
PBM Polytex Ltd. has re-appointed Mr. Gopal Patodia as Managing Director for a three-year term effective April 1, 2027. The appointment remains subject to shareholder approval.
- Execution
- 3 years
PBM Polytex Q1 FY27 Results: Turns Profitable, Net Profit ₹2 Cr
PBM Polytex Ltd reported revenue from operations of ₹38.8 Cr (-16.6% YoY) and net profit of ₹2 Cr for Q1 FY27.
- Key figure
- Net profit ₹2 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.